Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading Companies - Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, Biocodex
12 févr. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading Companies - Alnylam Pharmaceuticals, Dicerna...